Cyclerion Therapeutics, Inc. Common Stock
CYCN Real Time Price USDRecent trades of CYCN by members of U.S. Congress
No Congress Trading data for this ticker
Congress Trading Dashboard
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes by institutional investors
Quarterly net insider trading by CYCN's directors and management
No recent Insider Trading for this ticker
Insider Trading DashboardGovernment lobbying spending instances
No Corporate Lobbying instances for this ticker
Corporate Lobbying DashboardEstimated quarterly lobbying spending
No Corporate Lobbying data for this ticker
Corporate Lobbying DashboardNew patents grants
-
Patent Title: Processes and intermediates for the preparation of soluble guanylate cyclase stimulators Jul. 09, 2024
-
Patent Title: Processes for preparation of soluble guanylate cyclase stimulators Dec. 05, 2023
-
Patent Title: Process for preparation of soluble guanylate cyclase stimulators Oct. 03, 2023
-
Patent Title: Sgc stimulators Aug. 22, 2023
-
Patent Title: Processes and intermediates for the preparation of soluble guanylate cyclase stimulators Jul. 25, 2023
-
Patent Title: Treatment of cns diseases with sgc stimulators Jul. 04, 2023
-
Patent Title: Solid forms of an sgc stimulator Feb. 07, 2023
-
Patent Title: Crystalline forms of 8-(2-fluorobenzyl)-6-(3-(trifluoromethyl)-1h-1,2,4-triazol-5-yl)imidazo[1,2-a]pyrazine as sgc stimulators Oct. 11, 2022
-
Patent Title: Process for preparing soluble guanylate cyclase stimulators Oct. 11, 2022
-
Patent Title: Treatment of metabolic syndrome with an sgc stimulator Jul. 19, 2022
-
Patent Title: Use of sgc stimulators for the treatment of nonalcoholic steatohepatitis (nash) Jun. 14, 2022
-
Patent Title: Processes for preparation of soluble guanylate cyclase stimulators May. 03, 2022
-
Patent Title: Processes and intermediates for the preparation of soluble guanylate cyclase stimulators Mar. 15, 2022
-
Patent Title: Sgc stimulators Dec. 28, 2021
-
Patent Title: Sgc stimulators Nov. 23, 2021
-
Patent Title: Phosphorus prodrugs of pyrazolo-substituted pyrimidine sgc stimulators Feb. 23, 2021
-
Patent Title: Solid forms of an sgc stimulator Jan. 12, 2021
-
Patent Title: Sgc stimulators Dec. 08, 2020
-
Patent Title: Sgc stimulators Nov. 24, 2020
-
Patent Title: Sgc stimulators May. 05, 2020
-
Patent Title: Sgc stimulators Dec. 31, 2019
-
Patent Title: Sgc stimulators Nov. 12, 2019
Federal grants, loans, and purchases
No Government Contracts for this ticker
Government Contracts DashboardEstimated quarterly amount awarded from public contracts
Number of mentions of CYCN in WallStreetBets Daily Discussion
Recent insights relating to CYCN
Recent picks made for CYCN stock on CNBC
ETFs with the largest estimated holdings in CYCN
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CYCN Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.